{
  "trial_id": "NCT00446251",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age range 18 - 75, inclusive",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Able and willing to give written informed consent and comply with the requirements of the study protocol",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Outpatient status",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Patients with a Panel of Reactive Antibodies (PRA) over 10% after an 8-month trial of MMF monotherapy",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Patients with updated immunizations for tetanus, influenza, hepatitis B, pneumococcus",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Patients with a negative purified protein derivative(PPD ) screen for tuberculosis (TB)within the last 6 months.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Women who are of childbearing potential must have a negative serum pregnancy test prior to being enrolled in the study and agree to use a medically acceptable method of contraception throughout the study and for twelve months (1 year) after completion of treatment.",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Liver enzymes ALT and AST less than 2 times the normal limit.",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Active infection",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Receipt of live vaccine within 4 weeks prior to first infusion.",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Previous treatment with rituximab (MabThera\u00ae / Rituxan\u00ae)",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "History of multiple recurrent infections defined as more than 3 urinary tract infections, 2 episodes of pneumonia or 3 episodes of otitis/sinusitis in one year, or more than two dialysis line or peritoneal infections within one year.",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Infection with hepatitis C virus (HCV) or hepatitis B virus(HBV) or human immunodeficiency virus (HIV), lack of documentation of treatment of a positive PPD, pregnant or breast-feeding, baseline leukopenia, white blood cell count (WBC) less than 4.0, thrombocytopenia (platelet count less than 100,000/mm) or difficult to treat anemia, a hematocrit chronically less than 32 on intravenous iron and EPO (erythropoietin) therapy, history of severe allergic or anaphylactic reactions to humanized or murine monoclonal antibodies.",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Concomitant malignancies or previous malignancies within the last five years, with the exception of adequately treated basal or squamous cell carcinoma of the skin or carcinoma in situ of the cervix.",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "The patient is a pregnant woman who developed a sudden onset of fever and chills, accompanied by nausea and vomiting. She also complains of dysuria, urgency, and frequency. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts.",
  "_meta": {
    "topic_id": "51",
    "trial_id": "NCT00446251",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}